Wissous, France

Jonathan Reid Frost


Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 170(Granted Patents)


Location History:

  • Palaiseau, FR (1981 - 1982)
  • Cachan, FR (1984 - 1985)
  • Wissous, FR (1986 - 2008)

Company Filing History:


Years Active: 1981-2008

Loading Chart...
23 patents (USPTO):Explore Patents

Title: The Contributions of Jonathan Reid Frost to Pharmaceutical Innovations

Introduction: Jonathan Reid Frost is a notable inventor based in Wissous, France, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 23 patents, he has made strides in developing innovative solutions for complex medical challenges, particularly neurodegenerative diseases.

Latest Patents: Among his recent innovations, Frost has patented two notable inventions: the first pertains to 2-amino-3-(alkyl)-pyrimidone derivatives. This patent outlines a pyrimidone derivative represented by a specific formula or a salt thereof. It forms the basis of a medicament that includes this derivative or its salt as an active ingredient, aimed at preventive and therapeutic treatment of neurodegenerative diseases linked to the abnormal activity of GSK3β, such as Alzheimer’s disease. His second patent details a process for preparing pyridinyl and pyrimidinyl mono-fluorinated beta keto esters. This process involves synthesizing these esters, which are of considerable interest in pharmaceutical applications.

Career Highlights: Throughout his career, Jonathan Reid Frost has made significant contributions while working with leading pharmaceutical companies, including Synthelabo and Mitsubishi Pharma Corporation. His work in these organizations has allowed him to play a crucial role in the advancement of innovative therapeutic solutions.

Collaborations: In his endeavors, Frost collaborated with several esteemed colleagues such as Patrick Andre Lardenois and Alexander E Wick. Their combined expertise has fostered an environment of creativity and innovation, leading to breakthroughs in drug development.

Conclusion: Jonathan Reid Frost’s dedication to advancing pharmaceutical research and development is demonstrated through his extensive patent portfolio and collaborative efforts. His work not only contributes to expanding scientific knowledge but also promises improved treatment options for patients suffering from challenging conditions like neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…